These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26790383)

  • 21. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Moczulski D; Klupa T; Kozek E; Sieradzki J
    Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):505-9. PubMed ID: 14714273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease.
    Ortlepp JR; Lauscher J; Hoffmann R; Hanrath P; Joost HG
    Diabet Med; 2001 Oct; 18(10):842-5. PubMed ID: 11678976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece.
    Panierakis C; Goulielmos G; Mamoulakis D; Petraki E; Papavasiliou E; Galanakis E
    Clin Immunol; 2009 Nov; 133(2):276-81. PubMed ID: 19734102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D receptor (BsmI) gene polymorphism and allele frequency among chronic kidney disease patients in south Indian population.
    Badrachalam R; Mani V; Kumar R; Shafiulla A
    Bioinformation; 2023; 19(4):380-384. PubMed ID: 37822821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density.
    Kiel DP; Myers RH; Cupples LA; Kong XF; Zhu XH; Ordovas J; Schaefer EJ; Felson DT; Rush D; Wilson PW; Eisman JA; Holick MF
    J Bone Miner Res; 1997 Jul; 12(7):1049-57. PubMed ID: 9200004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population.
    Stefanić M; Papić S; Suver M; Glavas-Obrovac L; Karner I
    Int J Immunogenet; 2008 Apr; 35(2):125-31. PubMed ID: 18279374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
    Avila M; Prado C; Ventura MD; Mora C; Briones D; Valdez H; Hurtado ME; Lindholm B; Qureshi A; Castillo-Henkel C; Paniagua R
    Nephrol Dial Transplant; 2010 Jul; 25(7):2259-65. PubMed ID: 20124547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients.
    Marco MP; Craver L; Betriu A; Fibla J; Fernández E
    Am J Kidney Dis; 2001 Nov; 38(5):965-74. PubMed ID: 11684548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.
    Buraczynska M; Baranowicz-Gaszczyk I; Borowicz E; Ksiazek A
    Nephron Physiol; 2007; 106(4):p69-75. PubMed ID: 17622752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinopathy and nephropathy in type 1 diabetic patients--association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and IL-1 receptor 1 genes.
    Bućan K; Ivanisević M; Zemunik T; Boraska V; Skrabić V; Vatavuk Z; Galetović D; Znaor L
    Coll Antropol; 2009 Dec; 33 Suppl 2():99-105. PubMed ID: 20120526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population.
    Pan XM; Li DR; Yang L; Wang EY; Chen TY; Liu YJ; Liu M; Liao ZG
    DNA Cell Biol; 2009 Oct; 28(10):521-5. PubMed ID: 19563249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
    Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter polymorphism at the tumour necrosis factor/lymphotoxin-alpha locus is associated with type of diabetes but not with susceptibility to sight-threatening diabetic retinopathy.
    Kaidonis G; Craig JE; Gillies MC; Abhary S; Essex RW; Chang JH; Pal B; Pefkianaki M; Daniell M; Lake S; Petrovsky N; Burdon KP
    Diab Vasc Dis Res; 2016 Mar; 13(2):164-7. PubMed ID: 26821796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes.
    Nosratabadi R; Arababadi MK; Salehabad VA; Shamsizadeh A; Mahmoodi M; Sayadi AR; Kennedy D
    Int J Immunogenet; 2010 Dec; 37(6):493-7. PubMed ID: 20727043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of JAZF1, ABCC8, KCNJ11and Notch2 genes and vitamin D receptor polymorphisms in type 2 diabetes, and their association with microvascular complications.
    Rasheed MA; Kantoush N; Abd El-Ghaffar N; Farouk H; Kamel S; Ibrahim AA; Shalaby A; Mahmoud E; Raslan HM; Saleh OM
    Ther Adv Endocrinol Metab; 2017 Jun; 8(6):97-108. PubMed ID: 28794851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between aldose reductase gene C106T polymorphism and the severity of retinopathy in Type 2 diabetic patients: A case-control study.
    Abu-Hassan DW; Al-Bdour MD; Saleh I; Freihat M; El-Khateeb M
    J Res Med Sci; 2021; 26():2. PubMed ID: 34084181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism in the
    Lee DH; Won GW; Lee YH; Shin JS; Ku EJ; Oh TK; Jeon HJ
    Diab Vasc Dis Res; 2021; 18(5):14791641211041225. PubMed ID: 34488469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.